Literature DB >> 28898680

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity.

Miranda L Broz, Mikhail Binnewies, Bijan Boldajipour, Amanda E Nelson, Joshua L Pollack, David J Erle, Andrea Barczak, Michael D Rosenblum, Adil Daud, Diane L Barber, Sebastian Amigorena, Laura J Van't Veer, Anne I Sperling, Denise M Wolf, Matthew F Krummel.   

Abstract

Year:  2014        PMID： 28898680     DOI： 10.1016/j.ccell.2014.11.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  56 in total

Review 1.  Dysfunction of antigen processing and presentation by dendritic cells in cancer.

Authors:  Joanna Bandola-Simon; Paul A Roche
Journal:  Mol Immunol       Date:  2018-04-05       Impact factor: 4.407

2.  IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

Authors:  Ran You; Francesco J DeMayo; Jian Liu; Sung-Nam Cho; Bryan M Burt; Chad J Creighton; Roberto F Casal; Donald R Lazarus; Wen Lu; Hui-Ying Tung; Xiaoyi Yuan; Andrea Hill-McAlester; Myunghoo Kim; Sarah Perusich; Loraine Cornwell; Daniel Rosen; Li-Zhen Song; Silke Paust; Gretchen Diehl; David Corry; Farrah Kheradmand
Journal:  Cancer Immunol Res       Date:  2018-04-13       Impact factor: 11.151

3.  Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.

Authors:  Wenwen Xu; Juan Dong; Yongwei Zheng; Juan Zhou; Ying Yuan; Hieu Minh Ta; Halli E Miller; Michael Olson; Kamalakannan Rajasekaran; Marc S Ernstoff; Demin Wang; Subramaniam Malarkannan; Li Wang
Journal:  Cancer Immunol Res       Date:  2019-07-24       Impact factor: 11.151

4.  PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures.

Authors:  Kathryn M Appleton; Ashley K Elrod; Katy A Lassahn; Stephen Shuford; Lillia M Holmes; Teresa M DesRochers
Journal:  Cancer Immunol Immunother       Date:  2021-01-25       Impact factor: 6.968

5.  Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.

Authors:  Ilgen Mender; Anli Zhang; Zhenhua Ren; Chuanhui Han; Yafang Deng; Silvia Siteni; Huiyu Li; Jiankun Zhu; Aishwarya Vemula; Jerry W Shay; Yang-Xin Fu
Journal:  Cancer Cell       Date:  2020-07-02       Impact factor: 31.743

6.  Systemic Immunity Is Required for Effective Cancer Immunotherapy.

Authors:  Matthew H Spitzer; Yaron Carmi; Nathan E Reticker-Flynn; Serena S Kwek; Deepthi Madhireddy; Maria M Martins; Pier Federico Gherardini; Tyler R Prestwood; Jonathan Chabon; Sean C Bendall; Lawrence Fong; Garry P Nolan; Edgar G Engleman
Journal:  Cell       Date:  2017-01-19       Impact factor: 41.582

Review 7.  Host tissue determinants of tumour immunity.

Authors:  Hélène Salmon; Romain Remark; Sacha Gnjatic; Miriam Merad
Journal:  Nat Rev Cancer       Date:  2019-04       Impact factor: 60.716

8.  PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.

Authors:  Yuan Zhuang; Sihan Li; Huihui Wang; Jingbo Pi; Yuhui Xing; Guang Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

9.  In situ neutrophil efferocytosis shapes T cell immunity to influenza infection.

Authors:  Kihong Lim; Tae-Hyoun Kim; Alissa Trzeciak; Andrea M Amitrano; Emma C Reilly; Hen Prizant; Deborah J Fowell; David J Topham; Minsoo Kim
Journal:  Nat Immunol       Date:  2020-08-03       Impact factor: 25.606

10.  Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy.

Authors:  Sandeep T Koshy; Alexander S Cheung; Luo Gu; Amanda R Graveline; David J Mooney
Journal:  Adv Biosyst       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.